NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Proterra Inc. (NASDAQ: PTRA) between August 2, 2022 and March 15, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]
Read More »ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]
Read More »EB5 Capital’s Riverfront at the Navy Yard (JF8) Project Receives First I-829 Approval
WASHINGTON, July 24, 2023 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce that it has received notice from the United States Citizenship and Immigration Services (USCIS) regarding the first I-829 petition approval associated with an investor in the firm’s Riverfront at the Navy Yard (JF8) project. The I-829 approval marks a significant achievement for […]
Read More »APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to the investing public. SO WHAT: If […]
Read More »Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™) ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia […]
Read More »OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office
London, UK, July 24, 2023 (GLOBE NEWSWIRE) — OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, today announced a new team of experts will lead its HEOR & Market Access Scientific Office. This expert team will be led by Dr. Elisabeth Fenwick as Chief Scientific Officer with support from Professor Ben van […]
Read More »Ai-Media Introduces LEXI Viewer: Revolutionizing Live Events with Cutting-Edge Captioning Solution
LEXI Viewer BROOKLYN, N.Y., July 19, 2023 (GLOBE NEWSWIRE) — Ai-Media, the industry leader in technology-driven live captioning, transcription, and translation solutions, is delighted to unveil the ground-breaking LEXI Viewer. This innovative solution revolutionizes how event organizers captivate audiences. Say farewell to the constraints of traditional approaches and prepare to embrace a new era of unrivalled event […]
Read More »
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service